Cargando…
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242986/ https://www.ncbi.nlm.nih.gov/pubmed/35637283 http://dx.doi.org/10.1038/s41423-022-00882-1 |
| _version_ | 1784738192550789120 |
|---|---|
| author | Ding, Shu Rao, Yu Lu, Qianjin |
| author_facet | Ding, Shu Rao, Yu Lu, Qianjin |
| author_sort | Ding, Shu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9242986 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92429862022-07-01 Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? Ding, Shu Rao, Yu Lu, Qianjin Cell Mol Immunol Comment Nature Publishing Group UK 2022-05-30 2022-07 /pmc/articles/PMC9242986/ /pubmed/35637283 http://dx.doi.org/10.1038/s41423-022-00882-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Comment Ding, Shu Rao, Yu Lu, Qianjin Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title | Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title_full | Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title_fullStr | Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title_full_unstemmed | Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title_short | Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? |
| title_sort | are bcl6 and ezh2 novel therapeutic targets for systemic lupus erythematosus? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242986/ https://www.ncbi.nlm.nih.gov/pubmed/35637283 http://dx.doi.org/10.1038/s41423-022-00882-1 |
| work_keys_str_mv | AT dingshu arebcl6andezh2noveltherapeutictargetsforsystemiclupuserythematosus AT raoyu arebcl6andezh2noveltherapeutictargetsforsystemiclupuserythematosus AT luqianjin arebcl6andezh2noveltherapeutictargetsforsystemiclupuserythematosus |